AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04941144 — intervention group
Intervention type: BIOLOGICAL
Intervention: COVID-19 Vaccine
Description: COVID-19 Vaccine Intramuscular Injection
Study NCT04840472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 111I-n panitumumab
Description: Imaging Agent
Study NCT04840472 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single photon emission computed tomography/computed tomography (SPECT/CT) scans
Description: Day 1 to 5 (Day of Surgery inclusive)
Study NCT05699174 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care PO (oral) antibiotics
Description: An intervention in this study includes randomization of patients with an infected nonunion to PO (oral) antibiotics for up to 6 weeks post hospitalization. The exact type of oral antibiotic will be depended on the patient's infection diagnosis.
Study NCT05699174 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Intravenous (IV) antibiotics
Description: An intervention in this study includes randomization of patients with an infected nonunion to intravenous (IV) antibiotics for up to 6 weeks post hospitalization. The exact type of IV antibiotic will be depended on the patient's infection diagnosis.
Study NCT06387680 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Peanut Ball Use on Labor Memory, Labor Satisfaction, Delivery Length, and Neonatal APGAR Score: A Randomized Controlled Trial
Description: The Effect of Peanut Ball Use on Labor Memory, Labor Satisfaction, Delivery Length, and Neonatal APGAR Score: A Randomized Controlled Trial
Study NCT01297400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Investigational Drug, MW-III
Description: Topical application, twice a day
Study NCT01297400 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Silvadene® Cream 1% [Silver Sulfadiazine]
Description: Topical application, twice a day
Study NCT04428606 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Metabolic Rheostat
Description: Metabolic Rheostat™ Ingredients: Ginseng extract, Ginseng root extract, berberine chloride, Livaux (gold kiwi powder), MegaSporeBiotic, and MenaquinGold (vitamin K2-7) powder
Study NCT04428606 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Butyrate Ultra
Description: An anerobic probiotic supplement that contains butyrate-producing Butyricicoccus pullicaecorum 25-3T, vitamin K2, and fenugreek to maintain healthy glucose balance.
Study NCT04428606 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06318533 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anti-CD19 CAR NK cells
Description: Patients will receive Fludarabine (30mg/m2 per day) and Cyclophosphamide (300mg/m2 per day) on day -5, -4, and -3, followed by Anti-CD19 CAR NK cells infusion.
Study NCT06233526 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chemotherapy regiments based on the transcriptomic profile and in vitro drug sensitivity test
Description: 1. Leukemia cells from newly diagnosed and relapsed children with AML were tested for high throughput in vitro drug sensitivity and resistance.~2. Combined with multi-omics sequencing technology such as whole exome and transcriptome, the data of drug sensitivity, drug resistance and genomic characteristics of children AML patients were integrated, and the internal rules between drug sensitivity or drug resistance and molecular characteristics such as gene fusion, gene mutation and abnormal gene expression of children AML patients were deeply analyzed, and the molecular characteristics of drug sensitivity in children AML were mapped
Study NCT05490420 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: manual lymphatic drainage (MLD)
Description: MLD is a manual technique that is applied to the lymphatic system with a pressure of approximately 40-50mmHg and increases the working speed of lymphatic nodules/collectors. Its main purpose is to support microcirculation by accelerating lymphatic flow and to prevent/remove interstitial fluid accumulation that may cause fascial adhesions.
Study NCT05490420 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual lymphatic drainage (MLD)
Description: MLD is a manual technique that is applied to the lymphatic system with a pressure of approximately 40-50mmHg and increases the working speed of lymphatic nodules/collectors. Its main purpose is to support microcirculation by accelerating lymphatic flow and to prevent/remove interstitial fluid accumulation that may cause fascial adhesions.
Study NCT04506294 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eScreen system
Description: The eScreen system is composed of a child screening component and a parent information component. The child screening component is delivered via a game-like interface and includes assessment of current pain, PTSS, and functional recovery. Children are asked to play the game at least 3x/week. The parent information component consists of text / email messages sent to parents at least weekly that summarize child ratings and include a link to an online dashboard with additional personalized information for parents.
Study NCT06483880 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albendazole
Description: Patients will receive albendazole therapy at the recommended dosage.
Study NCT06483880 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive the placebo, which will be starch tablets in the same dosage of albendazole.
Study NCT06388473 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored implementation intervention
Description: The tailored implementation intervention comprised of six implementation strategies: 1) Involve executive boards, 2) Mandate change, 3) Provide education and training, 4) Identify and prepare champions, 5) The use of information and communication technology and 6) Audit and provide feedback.
Study NCT05506397 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure
Description: Acupressure is a technique based on stimulating certain points on the body with stimulation methods such as hands and fingers.
Study NCT05506397 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Acupressure
Description: Acupressure is a technique based on stimulating certain points on the body with stimulation methods such as hands and fingers.
Study NCT04957290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NOX66
Description: NOX66 800 mg daily (400 mg suppository twice daily \[BID\]).
Study NCT04957290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NOX66
Description: NOX66 1200 mg daily (600 mg suppository BID).
Study NCT04957290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NOX66
Description: NOX66 1600 mg daily (800 mg suppository BID).
Study NCT04957290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NOX66
Description: NOX66 2400 mg daily (1200 mg suppository BID).
Study NCT04957290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NOX66
Description: NOX66 RP2D
Study NCT04957290 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: EBRT
Description: The dose levels of EBRT will be either 8 Gy as a single fraction, or 20/25 Gy as 5 fractions given over 5 to 10 days.
Study NCT04780542 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yo Puedo Sentirme Bien- Clinician-Guided version
Description: Internet delivered Cognitive Behavioral Therapy- Guided version
Study NCT04780542 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Yo Puedo Sentirme Bien- Self-Guided version
Description: Internet delivered Cognitive Behavioral Therapy- Self-Guided version
Study NCT05399316 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Inulin
Description: Natural fiber supplement extracted from chicory
Study NCT05399316 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Natural non-fermentable sugar
Study NCT05227339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RAE
Description: Subjects in the interventional group will have access to the RAE Health mobile app which receives continuous physiologic data from a wearable device. Algorithms embedded in the RAE app detect stress and craving events, and trigger mobile phone notifications when detected. Notifications are paired to real-time mindfulness based interventions.
Study NCT05589285 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Injection of autologous whole blood to the plantar fascia
Description: Patients assigned in this group will have 2 ml of blood withdrawn from a peripheral vein, then mixed with 1 mL Lidocaine 2% for a total of 3mL volume in one syringe. The patient will be asked to lie down in the clinic bed, and the injection will be administered to the plantar fascia by the principal investigator using a sterile technique.
Study NCT05589285 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Injection of normal saline to the plantar fascia
Description: This will be the control group receiving sham injection. Patients will have 2 ml of blood withdrawn from a peripheral vein for blinding proposes. They will be asked to lie down on the clinic bed, 1 ml of normal saline will be administered under sterile technique by the principal investigator. The blood that was withdrawn initially will be discarded.
Study NCT05597293 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Glucose monitoring using FreeStyle Libre 2
Description: Glucose monitoring in patients with type 2 diabetes using FreeStyle Libre 2
Study NCT05597293 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Glucose monitoring using FreeStyle Libre pro iQ
Description: Glucose monitoring in patients with type 2 diabetes using FreeStyle Libre pro iQ
Study NCT05449704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-5218
Description: single dose administration (DA-5218 one tablet once a day)
Study NCT05449704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-5218-R1 + DA-5218-R2 + DA-5218-R3
Description: single dose administration (DA-5218-R1 one tablet once a day + DA-5218-R2 one tablet once a day + DA-5218-R3 one tablet once a day)
Study NCT05249478 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine and fentanyl
Description: bupivacaine and fentanyl will be infused through the catheter
Study NCT05019118 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental milk
Description: UNICLA milk naturally enriched in selenium and omega-3.
Study NCT05019118 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental yogur
Description: UNICLA yogur naturally enriched in selenium and omega-3.
Study NCT05019118 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental fresh cheese
Description: UNICLA fresh cheese naturally enriched in selenium and omega-3.
Study NCT05019118 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo milk
Description: Conventional milk
Study NCT05019118 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo yogur
Description: Conventional yogur
Study NCT05019118 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo fresh cheese
Description: Conventional fresh cheese
Study NCT06304467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency Management
Description: Study subjects who have received a liver transplant and have been randomized to the treatment arm will receive contingency management, a positive reinforcement behavioral treatment with escalating rewards for consecutive either negative urine and blood tests (or lower value of metabolites than the previous week for PeTH) depending on which results are received first, capped at a maximum of $80 (in the form of a gift card) at the week 10 visit.
Study NCT05082597 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low energy ESWT
Description: Therapeutic sessions: 4(once a week, for 4 weeks) Total dosage: 2500 shoots over axillary cord lesion (1000 over most fibrotic area, 500 over upper arm, 500 over forearm, 500 over other area) Energy: 0.056-0.065mJ/mm2
Study NCT05864092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Goggles
Description: We will offer patients virtual reality goggles with guided meditation software in addition to standard medical therapy (NSAID and opioid).
Study NCT04960839 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Prophylactic contralateral breast irradiation
Description: The whole contralateral breast will be irradiated once daily, 5 days a week, for 5-6 weeks, using 1.8-2 Gy/fx to a total dose of 45-50 Gy.
Study NCT05066542 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NDPP + Basketball (BB)
Description: DPP Hoops: Participants in this arm will participate in the traditional NDPP program delivered virtually by certified NDPP coaches along with virtual fitness sessions and in-person basketball sessions. During Months 1-4, participants will attend a 60-minute virtually facilitated session of the NDPP curriculum, followed by a 30- minute virtual fitness session. During that same week, participants will meet in person, for a 90-minute BB session. During Months 5-8, virtual NDPP curriculum sessions will be held every two weeks and there will no longer be a 30-minute online fitness session succeeding the session. During this same four-month period, 60-minute, in-person BB sessions will be held weekly. During Months 9-12, participants will attend a monthly 60-minute NDPP curriculum session and biweekly 60-minute in-person BB sessions. Participants will submit a weekly weight report during the 12 month participation and will complete the ASA 24 hour food recall every 90 days.
Study NCT05066542 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NDPP Standard of Care SOC
Description: DPP: Participants in this arm will participate in the traditional NDPP program delivered virtually by certified NDPP coaches. During Months 1-4 participants will attend a 60-minute virtually facilitated session of the NDPP curriculum. During Months 5-8, virtual NDPP curriculum sessions will be held every two weeks. During Months 9-12, participants will attend a monthly 60-minute NDPP curriculum session. Participants will submit a weekly weight report during the 12 month participation and will complete the ASA 24 hour food recall every 90 days.
Study NCT06131099 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dohsa hou exercises
Description: Dohsa hou is a type of psychomotor therapy that helps improve psychological problems by using bodily movements, sensation and relaxation experience.
Study NCT06131099 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment protocal
Description: Standard treatment including soft tissue massage therapy, task specific training interventions, bicycle training and aerobic exercises.
Study NCT06337019 — intervention group
Intervention type: OTHER
Intervention: Cohort observational
Description: Cohort observational
Study NCT05501119 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A Program of SUPPORT-D (dementia)
Description: The SUPPORT-D intervention consists educational materials will be presented in a format with enhanced content (face-to-face virtually delivered by nurse interventionist via telehealth (e.g., MS Teams), with printed booklet, and identical digital content (electronic pdf and recorded videos of printed content). The SUPPORT-D intervention will be addressed in four sequential sections including: 1) understanding the disease 2) caring for myself; 3) information for the caregiver; and 4) planning for the future. Within the four sections of the intervention seven topics are addressed included symptom management, understanding your disease, putting safety first, ongoing conversations, respite care, palliative care, and alternative treatments. Participants will attend a total of 4 study visits across 8 weeks (approximately every 2 weeks).
Study NCT06162208 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard exercise program based on telerehabilitation
Description: Exercises included in a standard exercise program based on telerehabilitation; Week 0-3 Patellar mobilization Isometric quadriceps femoris exercise Terminal extension exercise Active assisted knee flexion Straight leg lift Active hip abduction Active assisted knee flexion in sitting SAFTE Cold pack application Week 3-6 Straight leg raises with weights Hip abduction in weighted side lying Knee flexion in the prone position Knee extension in weight-bearing sitting Sliding forward in the chair to increase the knee flexion angle Standing weighted hip abduction Standing knee flexion with weight Squat Walking Climbing stairs Action observation therapy will be practiced by watching videos of all exercises with a focus on close-up action.
Study NCT05697185 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evolocumab
Description: Patients were randomly assigned of the ratio of 1:1 using a computer-generated random number and divided into two treatment groups: the statin alone therapy and the evolocumab plus statin therapy.
Study NCT05412446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADAPT6-SPECT
Description: Diagnostic SPECT for HER2 expression in primary tumour and metastatic lymph nodes
Study NCT06297772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: decitabine 20mg/m2 per day for consecutive 5 days
Study NCT06297772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine Injection
Description: fludarabine 30mg/m2 per day for consecutive 5 days
Study NCT06297772 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludarabine Injection
Description: fludarabine 30mg/m2 per day for consecutive 5 days
Study NCT06297772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan Injection
Description: Busulfan 3.2mg/kg per day for consecutive 4 days
Study NCT06297772 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Busulfan Injection
Description: Busulfan 3.2mg/kg per day for consecutive 4 days
Study NCT04646434 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electroencephalography
Description: Undergo EEG
Study NCT04646434 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electromyography
Description: Undergo EMG
Study NCT04646434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Complete questionnaire
Study NCT04646434 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Urodynamics (UDS)
Description: Undergo UDS
Study NCT04313140 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Diagnostic test
Description: The intervention occurs only one time (for 2h30), the MRI examination is divided as follow:~* Cinicial MRI (50 minutes)~* Research MRI (Phosphorus Spectroscopy, Sodium Imaging)
Study NCT04945798 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: OMT
Description: OMT: direct myofascial release for the triplanar diagnonosis to the OA, thoracic outlet, respiratory diaphragm and pelvic diaphragm concluding with a pedal pump for 120 seconds
Study NCT04448990 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS eco 2 Transauricular vagal nerve stimulation
Description: Auricular electrical stimulation will be applied bilaterally using Transcutaneous Electrical Nerve Stimulation device TENS eco 2 (Schwa-Medico, Pierenkemper GmbH, Ehringshausen, Germany).~tVNS will be applied bilaterally using electrical square impulses delivered in blocks of 9 impulses with a frequency of 100 Hz and a pulse width of 200 μs emitted twice per second resulting in mixed frequency pattern of 100 Hz/2 Hz with the current intensity, that will be individually adjusted for each ear separately until the maximal tVNS intensity, which is not uncomfortable or painful, will be achieved.
Study NCT04448990 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham TENS eco 2
Description: Sham
Study NCT06056752 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QH103 Cell Injection
Description: dose escalation (3+3) : dose 1 (3×10\^8CAR+cells) ,dose 2 (1 × 10\^9 CAR+cells）,dose 3 (3 × 10\^9CAR+cells)
Study NCT06056752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Intravenous fludarabine on days-5\~-2,the infusion dose is adjusted according to the subject's condition
Study NCT06056752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous cyclophosphamide on days -5\~-3, the infusion dose is adjusted according to the subject's condition
Study NCT05526027 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: CFQ-R questionnaire, SNOT-22 questionnaire, fecal elastase measurement
Description: cf supra
Study NCT06233695 — intervention group
Intervention type: DRUG
Intervention: Potassium sparing diuretic
Description: Starting Spironolactone or Eplerenone at the time of enrollment.
Study NCT06444646 — intervention group
Intervention type: OTHER
Intervention: Adipose tissue biopsy
Description: From each patient, two biopsies will be taken during surgery; one from the subcutaneous and one from the visceral adipose tissue.
Study NCT06444646 — intervention group
Intervention type: OTHER
Intervention: Blood sampling
Description: From each patient, two venous blood samples (citrate, LiHe and EDTA plasma) will be taken before surgery.
Study NCT06444646 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Before bariatric surgery, every patient will fill out questions about general health (physical activity, sedentary behavior, sleeping pattern, ...), physical condition before surgery (nausea, food intake, ...), etc.